Analysis of vkorc1 polymorphisms in Norway rats using the roof rat as outgroup

Díaz, Juan C.; Ying Song; Moore, Anthony; Borchert, Jeff N.; Kohn, Michael H.
January 2010
BMC Genetics;2010, Vol. 11, p43
Academic Journal
Background: Certain mutations in the vitamin K epoxide reductase subcomponent 1 gene (vkorc1) mediate rodent resistance to warfarin and other anticoagulants. Testing for resistance often involves analysis of the vkorc1. However, a genetic test for the roof rat (Rattus rattus) has yet to be developed. Moreover, an available roof rat vkorc1 sequence would enable species identification based on vkorc1 sequence and the evaluation of natural selection on particular vkorc1 polymorphisms in the Norway rat (R. norvegicus). Results: We report the coding sequence, introns and 5' and 3' termini for the vkorc1 gene of roof rats (R. r. alexandrinus and R. r. frugivorus) from Uganda, Africa. Newly designed PCR primers now enable genetic testing of the roof rat and Norway rat. Only synonymous and noncoding polymorphisms were found in roof rats from Uganda. Both nominal subspecies of roof rats were indistinguishable from each other but were distinct from R. losea and R. flavipectus; however, the roof rat also shares at least three coding sequence polymorphisms with R. losea and R. flavipectus. Many of recently published vkorc1 synonymous and non-synonymous single nucleotide polymorphisms (SNPs) in Norway rats are likely SNPs from roof rats and/or other Rattus species. Tests applied to presumably genuine Norway rat vkorc1 SNPs are consistent with a role for selection in two populations carrying the derived Phe63Cys and Tyr139Cys mutations. Conclusion: Geographic mapping of vkorc1 SNPs in roof rats should be facilitated by our report. Our assay should be applicable to most species of Rattus, which are intermediate in genetic distance from roof and Norway rats. Vkorc1- mediated resistance due to non-synonymous coding SNPs is not segregating in roof rats from Uganda. By using the roof rat sequence as a reference vkorc1, SNPs now can be assigned to the correct rat species with more confidence. Sampling designs and genotyping strategies employed so far have helped detect candidate mutations underlying vkorc1-mediated resistance, but generally provided unsuitable data to test for selection. We propose that our understanding of vkorc1-mediated evolution of resistance in rodents would benefit from the adoption of sampling and genotyping designs that enable tests for selection on vkorc1.


Related Articles

  • Identification of the gene for vitamin K epoxide reductase. Li, Tao; Chang, Chun-yun; Jin, Da-yun; Lin, Pen-jen; Khvorova, Anastasia; Stafford, Darrel W. // Nature;2/5/2004, Vol. 427 Issue 6974, p541 

    Vitamin K epoxide reductase (VKOR) is the target of warfarin, the most widely prescribed anticoagulant for thromboembolic disorders. Although estimated to prevent twenty strokes per induced bleeding episode, warfarin is under-used because of the difficulty of controlling dosage and the fear of...

  • Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Wadelius, M.; Chen, L. Y.; Downes, K.; Ghori, J.; Hunt, S.; Eriksson, N.; Wallerman, O.; Melhus, H.; Wadelius, C.; Bentley, D.; Deloukas, P. // Pharmacogenomics Journal;2005, Vol. 5 Issue 4, p262 

    We report a novel combination of factors that explains almost 60% of variable response to warfarin. Warfarin is a widely used anticoagulant, which acts through interference with vitamin K epoxide reductase that is encoded by VKORC1. In the next step of the vitamin K cycle, gamma-glutamyl...

  • Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing. Lenzini, P.; Wadelius, M.; Kimmel, S.; Anderson, J. L.; Jorgensen, A. L.; Pirmohamed, M.; Caldwell, M. D.; Limdi, N.; Burmester, J. K.; Dowd, M. B.; Angchaisuksiri, P.; Bass, A. R.; Chen, J.; Eriksson, N.; Rane, A.; Lindh, J. D.; Carlquist, J. F.; Horne, B. D.; Grice, G.; Milligan, P. E. // Clinical Pharmacology & Therapeutics;May2010, Vol. 87 Issue 5, p572 

    Well-characterized genes that affect warfarin metabolism (cytochrome P450 (CYP) 2C9) and sensitivity (vitamin K epoxide reductase complex 1 (VKORC1)) explain one-third of the variability in therapeutic dose before the international normalized ratio (INR) is measured. To determine genotypic...

  • A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9*. Lai-San Tham; Boon-Cher Goh; Nafziger, Anne; Jia-Yi Guo; Ling-Zhi Wang; Richie Soong; Soo-Chin Lee // Clinical Pharmacology & Therapeutics;Oct2006, Vol. 80 Issue 4, p346 

    Introduction: Because of the unique lack of genetic diversity despite the multiethnicity in the Asian population, we hypothesize that single-nucleotide polymorphisms in cytochrome P450 (CYP) 2C9 (CYP2C9*3) and vitamin K epoxide reductase complex subunit 1 (VKORC1) at position 381, used to infer...

  • VKORC1 −1639G>A and CYP2C9*3 are the major genetic predictors of phenprocoumon dose requirement. Puehringer, Helene; Loreth, Ralph; Klose, Gudrun; Schreyer, Brigitte; Krugluger, Walter; Schneider, Barbara; Oberkanins, Christian // European Journal of Clinical Pharmacology;Jun2010, Vol. 66 Issue 6, p591 

    Phenprocoumon, similar to other coumarin-derived anticoagulants, is associated with a large variation in the individual dose requirement to achieve stable anticoagulation. Polymorphisms in the vitamin K epoxide reductase complex subunit 1 (VKORC1) and the liver enzyme cytochrome P450 2C9...

  • Medicine: K is for koagulation. Sadler, J. Evan // Nature;2/5/2004, Vol. 427 Issue 6974, p493 

    Comparative genetic linkage studies in rats, mice and humans have finally identified a key component of vitamin K metabolism that is targeted by the commonest anticoagulant drugs in use. It was found that mutations in one particular gene occurred in two families with defective...

  • Vitamin K decreased INR but did not reduce bleeding in overanticoagulated patients on warfarin. Jacob, Harry S. // Hem/Onc Today;3/25/2009, Vol. 10 Issue 6, p42 

    The article discusses a study, published in a 2009 issue of "Annals of Internal Medicine, which examined the impact of low-dose oral vitamin K on the international normalized ratio of overanticoagulated patients who received warfarin.

  • The distribution and mechanisms of Super rats ? warfarin resistant black rats (Rattus rattus) ? in Japan. Tanaka, Kazuyuki // Japanese Journal of Veterinary Research;May2013, Vol. 61 Issue 1/2, p32 

    In this article, the author focuses on the distribution and mechanism of warfarin resistant black Rattus rattus also known as Super rats in Japan. He states that rats in the region have vitamin K 2,3-epoxide reductase (VKOR) activity, which is not inhibited by warfarin. He further mentions VKOR...

  • How to Eat Right When You Take Coumadin (Warfarin Sodium).  // Nutrition in Clinical Care;May/Jun98, Vol. 1 Issue 3, p168 

    Presents guidelines to get the maximum benefit from anticoagulation medication. Rule regarding the intake of vitamin K; Identification of foods with high, medium and low in vitamin K; Lists of foods and beverages affecting the action of warfarin in the body.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics